What should I Know Regarding Pregnancy, Nursing and Administering Duragesic Patch, Transdermal 72 Hours to Children or the Elderly?

If you are PREGNANT

  • Requires a Risk/Benefit Assessment:

If you are NURSING


If you are an adult over 60

  • management or monitoring precaution: Pulmonary-DO NOT USE in opioid intolerance. Life-threatening respiratory depression more likely to occur due to altered clearance. Use cautiously with respiratory disease, when initiating, titrating and giving with other respiratory depressants. Neuro/Psych-Risk for confusion, delirium and falls. Avoid treatment with 3 or more CNS active agents. Gastrointestinal-Increased rate of constipation in the elderly. Cardiovascular-Vasodilation may predispose to orthostatic hypotension.

Giving Duragesic Patch, Transdermal 72 Hours to a child under 12

  • Severe Precaution: Administration restricted to opioid tolerant patients. Risk of severe respiratory depression.
  • Contraindication: Safety not established age < 2 years. Risk of fatal respiratory depression in opioid-naive.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.